ZS-9: Phase III data

Top-line data from the double-blind, U.S. and Australian Phase III ZS-003 trial in 753 patients with mild to moderate hyperkalemia, defined as potassium levels of 5-6.5 mEq/L, showed that the 2.5, 5 and 10

Read the full 348 word article

User Sign In